Answers are grounded in this paper and cite their sources.
Preparatory study assesses physicochemical compatibility of infusion solutions to enhance safety in ICU patients.
Y-site administration of 16 binary admixtures identified as incompatible is not recommended. The preparatory study results are suitable to complete incompatibility-reducing infusion schemes. Clinical pharmacists should implement incompatibility-reducing tools in intensive care patients.
No takes yet. Share an insight, caveat, or question.
Kreysing et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: